Funding statement (financial disclosure): The Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) study was partly supported by EU Framework Program V grant QLG1-CT-2001-01252 with additional funding from AstraZeneca (Sweden). The gene discussed is INS; the disease is cardiovascular disorder.